Finacea’s generics by Glenmark is an infringe on Bayer AG’s Patent, US court
Advertisement
A US court has recently ruled the decision of proposal of the generic version of Finacea, a skin gel, as an act of infringement by Glenmark Pharmaceuticals. The proposed generic version is currently patented by Bayer AG, a gel for treating the common skin condition rosacea.
The federal court in Wilmington, Delaware is reported to have stressed on the fact that Glenmark's proposed gel would be absorbed into the skin in a similar way to Finacea, violating Bayer's patent.
Germany's Bayer had sued Glenmark in 2013 after Glenmark filed an application to market a copycat version of the $95 million drug in the United States
The federal court in Wilmington, Delaware is reported to have stressed on the fact that Glenmark's proposed gel would be absorbed into the skin in a similar way to Finacea, violating Bayer's patent.
Germany's Bayer had sued Glenmark in 2013 after Glenmark filed an application to market a copycat version of the $95 million drug in the United States
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.